Anemia is an independent risk for mortality after acute myocardial infarction in patients with and without diabetes

por Shu, David H, Ransom, Thomas PP, O'Connell, Colleen M, Cox, Jafna L, Kaiser, Stephanie M, Gee, Shirl A, Rowe, Richard C, Ur, Ehud, Imran, Syed Ali
Publicado 2006

MON-323 IGF-I Variability and Its Association with Demographic and Clinical Characteristics in Patients with Acromegaly Treated with Injectable Somatostatin Receptor Ligands (SRLS)...

por Samson, Susan Leanne, Nachtigall, Lisa B, Fleseriu, Maria, Ur, Ehud, Ludlam, William Henry, Patou, Gary, Haviv, Asi, Gilgun-Sherki, Yossi, Biermasz, Nienke, Strasburger, Christian Joseph, Kennedy, Laurence, Melmed, Shlomo
Publicado 2020

Patient Age, Ethnicity, Medical History, and Risk Factor Profile, but Not Drug Insurance Coverage, Predict Successful Attainment of Glycemic Targets: Time 2 Do More Quality Enhance...

por Teoh, Hwee, Braga, Manoela F.B., Casanova, Amparo, Drouin, Denis, Goodman, Shaun G., Harris, Stewart B., Langer, Anatoly, Tan, Mary K., Ur, Ehud, Yan, Andrew T., Zinman, Bernard, Leiter, Lawrence A.
Publicado 2010

Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide

por Samson, Susan L, Nachtigall, Lisa B, Fleseriu, Maria, Gordon, Murray B, Bolanowski, Marek, Labadzhyan, Artak, Ur, Ehud, Molitch, Mark, Ludlam, William H, Patou, Gary, Haviv, Asi, Biermasz, Nienke, Giustina, Andrea, Trainer, Peter J, Strasburger, Christian J, Kennedy, Laurence, Melmed, Shlomo
Publicado 2020